These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 7349668

  • 21. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J, von Pape KW, Blaurock M.
    Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
    [Abstract] [Full Text] [Related]

  • 22. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR, Mourão PA.
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [Abstract] [Full Text] [Related]

  • 23. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
    Okajima K, Ueyama H, Hashimoto Y, Sasaki Y, Matsumoto K, Okabe H, Inoue M, Araki S, Takatsuki K.
    Thromb Haemost; 1989 Feb 28; 61(1):20-4. PubMed ID: 2749590
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III.
    Cerskus AL, Birchall KJ, Ofosu FA, Hirsh J, Blajchman MA.
    Can J Biochem Cell Biol; 1984 Oct 28; 62(10):975-83. PubMed ID: 6509363
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Thrombin generation and inactivation in the presence of antithrombin III and heparin.
    Lindhout T, Baruch D, Schoen P, Franssen J, Hemker HC.
    Biochemistry; 1986 Oct 07; 25(20):5962-9. PubMed ID: 3790498
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics and pharmacodynamics of a low molecular weight heparin (enoxaparin) after subcutaneous injection, comparison with unfractionated heparin--a three way cross over study in human volunteers.
    Bendetowicz AV, Béguin S, Caplain H, Hemker HC.
    Thromb Haemost; 1994 Mar 07; 71(3):305-13. PubMed ID: 8029794
    [Abstract] [Full Text] [Related]

  • 32. [Effect of heparin cofactor II on the antithrombin III activities measured by thrombin methods or factor Xa methods--fundamental studies and clinical studies using the plasma of pregnant women].
    Akai Y, Shiga S, Tohyama K, Shimatsu A, Ichiyama S.
    Rinsho Byori; 2000 Sep 07; 48(9):867-71. PubMed ID: 11051806
    [Abstract] [Full Text] [Related]

  • 33. An improved heparin assay which is insensitive to platelet factor 4.
    Fickenscher K, Buckler U.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989 Sep 07; 116(6):873-8. PubMed ID: 2483705
    [Abstract] [Full Text] [Related]

  • 34. Molecular weight of heparin versus biologic activity. Some additional considerations.
    Losito R, Losito C.
    Semin Thromb Hemost; 1985 Jan 07; 11(1):29-33. PubMed ID: 2579437
    [No Abstract] [Full Text] [Related]

  • 35. GAGs-potentiated inhibition of thrombin, factor Xa and plasmin in plasma and in a purified system containing antithrombin III - correlation with total charge density.
    Cofrancesco E, Vigo A, Pogliani EM.
    Thromb Haemost; 1981 Dec 23; 46(4):749-51. PubMed ID: 6460339
    [Abstract] [Full Text] [Related]

  • 36. Antithrombin III Geneva: a hereditary abnormal AT III with defective heparin cofactor activity.
    de Moerloose PA, Reber G, Vernet P, Minazio P, Bouvier CA.
    Thromb Haemost; 1987 Apr 07; 57(2):154-7. PubMed ID: 3603409
    [Abstract] [Full Text] [Related]

  • 37. Effects of heparin oligosaccharides with high affinity for antithrombin III in experimental venous thrombosis.
    Thomas DP, Merton RE, Barrowcliffe TW, Thunberg L, Lindahl U.
    Thromb Haemost; 1982 Jun 28; 47(3):244-8. PubMed ID: 7112499
    [Abstract] [Full Text] [Related]

  • 38. Adverse effect of heparin in thrombin-antithrombin III interaction.
    Marciniak E.
    Thromb Diath Haemorrh; 1975 Dec 15; 34(3):748-62. PubMed ID: 1209544
    [Abstract] [Full Text] [Related]

  • 39. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential.
    Chan AK, Berry LR, Monagle PT, Andrew M.
    Thromb Haemost; 2002 Apr 15; 87(4):606-13. PubMed ID: 12008942
    [Abstract] [Full Text] [Related]

  • 40. Mechanism of action of an antithrombotic agent antithrombin III - factor Xa complex.
    Bajwa SS.
    Proc West Pharmacol Soc; 1982 Apr 15; 25():1-5. PubMed ID: 7122480
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.